J. Goldman & Co »

Immunovant shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-03-31 $708k 41k 17.09
2024-12-31 $851k 34k 24.77
2020-03-31 $412k 177k 2.32

More positions owned by J. Goldman & Co

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Maplebear (CART)
Steven Madden (SHOO)
Rocket Cos Com Cl A (RKT)
Sba Communications Corp Cl A (SBAC)
Amazon (AMZN)
Paypal Holdings (PYPL)
General Motors Company (GM)
Globus Med Cl A (GMED)
Centuri Holdings Com Shs (CTRI)
Rivian Automotive Com Cl A Call Option (RIVN)
Target Corporation (TGT)

View all positions for J. Goldman & Co

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
Armistice Capital
BlackRock
Baker Bros. Advisors
T. Rowe Price Investment Management
Point72 Asset Management
State Street Corporation
Two Seas Capital
Alpine Partners VI
Morgan Stanley
ADAR1 Capital Management
Stempoint Capital
Geode Capital Management

View all funds holding Immunovant